FABP and Some Related Diabetic Parameters Among Adolescents with Toxoplasma gondii
Main Article Content
Abstract
Recently, it has been revealed that Toxoplasmosis may be associated with some factors related to type 2 diabetes, such as glucose, insulin, the Homeostatic Model Assessment for Insulin Resistant (HOMA-IR), and Fatty acid binding protein (FABP). Therefore, the current study aimed to specify how Toxoplasma gondii (T.gondii) infection affects glucose, insulin, HOMA-IR, and FABP among adolescents. From October to December 2022, this study was carried out at Al Madain Hospital in Baghdad. For a group of adolescents visiting the hospital, an ELISA test was performed to check their anti-T.gondii antibodies. Ninety adolescents were selected to participate in the study on the basis of this examination. They were divided into two groups: those who tested positive for the parasite (n = 45) and those who tested negative (n = 45), the control group. Measurements were performed on each participant's adolescence: weight for age percentile, weight for age z score, glucose, insulin, HOMA-IR, and FABP. Results showed that the T. gondii positive group had a significantly (P˂0.05) higher weight for age percentile (86.84±2.66) and z score (1.29 ±0.11) versus the control group. Results also showed that those overweight adolescents with seropositive antibodies had significantly (P˂0.05) greater levels of each glucose, insulin, HOMA-IR , and FABP than did a seronegative group of adolescents
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
licenseTerms
Publication Dates
Received
Accepted
Published Online First
References
Dubey, J.; Jones, J. Toxoplasma gondii infection in humans and animals in the United States. International journal for parasitology 2008, 38, 1257-1278. doi: 10.1016/j.ijpara.2008.03.007
Abarikwu, S.O. Causes and risk factors for male-factor infertility in Nigeria: a review. African Journal of Reproductive Health 2013, 17. https://www.jstor.org/stable/24362421.
Baqer, N.N.; Saheb, E.J.; Ahmed, N.S.; Alhadad, N.A.A. The association of IL-3, IL-17A, and IL 27 serum levels with susceptibility to toxoplasmosis in recurrent abortion of Iraqi women. Experimental Parasitology 2022, 234, 108217.doi:10.1016/j.exppara.2022.108217
Kim, K.; Weiss, L.M. Toxoplasma: the next 100 years. Microbes and Infection 2008, 10, 978-984. doi: 10.1016/j.micinf.2008.07.015
Hill, D.; Dubey, J. Toxoplasma gondii: transmission, diagnosis and prevention.Clinical microbiology and infection 2002, 8, 634-640. doi:10.1046/j.1469-0691.2002.00485.x
Zghair, K.H.; Al-Qadhi, B.N.; Mahmood, S.H. The effect of toxoplasmosis on the level of some sex hormones in males blood donors in Baghdad. Journal of Parasitic Diseases 2015, 39, 393-400. doi:10.1007/s12639-013-0382-6
Aziz, F.M.; Drueish, M.J. Toxoplasmosis: serious disease during pregnancy. Baghdad Science Journal 2011, 6;8(1):91-5. https://doi.org/10.21123/bsj.2011.8.1.91-95
Reeves, G.M.; Postolache, T.T.; Mazaheri, S.; Snitker, S.; Langenberg, P.; Giegling, I.; Hartmann, A.; Konte, B.; Friedl, M.; Okusaga, O. A positive association between T. gondii seropositivity and obesity. Frontiers in public health 2013, 73.doi: 10.3389/fpubh.2013.00073
Ali, H.Z.; Al-Warid, H.S. Changes in Serum Levels of Lipid Profile Parameters and Proteins in Toxoplasma gondii Seropositive Patients. Iraqi Journal of Science 2021, 801-810. doi:https://doi.org/10.24996/ijs.2021.62.3.11
Xu, F.; Lu, X.; Cheng, R.; Zhu, Y.; Miao, S.; Huang, Q.; Xu, Y.; Qiu, L.; Zhou, Y. The influence of exposure to Toxoplasma Gondii on host lipid metabolism. BMC Infectious Diseases 2020, 20, 1-9. https://doi.org/10.1186/s12879-020-05138-9
Al-Khafajii, G.S.; Al-Warid, H.S.; Al-Abbudi, F.A. The association between Toxoplasma gondii seropositive status and diabetes mellitus in obese and non-obese subjects in Baghdad. Iraqi Journal of Science 2021, 1793-1803.https://doi.org/10.24996/ijs.2021.62.6.5
Elfadaly, H.A.; Hassanain, M.A.; Shaapan,R.M.; Hassanain, N.A.; Barakat, A.M. Corticosteroids opportunist higher Toxoplasma gondii brain cysts in latent infected mice. Int J Zool Res 2015, 11, 169-176. 10.3923/ijzr.2015.169.176
Moudgil, A.D.; Singla, L.D.; Sharma, A.; Bal, M.S. First record of Toxoplasma gondii antibodiesin Royal Bengal tigers (Panthera tigris tigris) and Asiatic lions (Panthera leo persica) in India. Veterinaria Italiana 2019, 55, 157-162. doi:10.12834/VetIt.971.5066.3
Beshay, E.V.N.; El-Refai, S.A.; Helwa, M.A.; Atia, A.F.; Dawoud, M.M. Toxoplasma gondii as a possible causative pathogen of type-1 diabetes mellitus: evidence from case-control and experimental studies. Experimental parasitology 2018, 188, 93-101. doi:10.1016/j.exppara.2018.04.007
Trojnar, M.; Patro-Małysza, J.; Kimber-Trojnar, Ż.; Leszczyńska-Gorzelak, B.; Mosiewicz, J. Associations between fatty acid-binding protein 4–A proinflammatory adipokine and insulin resistance, gestational and type 2 diabetes mellitus. Cells 2019, 8, 227. doi: 10.3390/cells8030227
Furuhashi, M.; Hotamisligil, G.S. Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nature reviews Drug discovery 2008, 7, 489-503.
Wang, B.; Xu, J.; Ren, Q.; Cheng, L.; Guo, F.; Liang, Y.; Yang, L.; Tan, Z.; Fu, P.; Ma, L. Fatty acid-binding protein 4 is a therapeutic target for septic acute kidney injury by regulating inflammatory response and cell apoptosis. Cell Death & Disease 2022, 13, 333. doi:10.1038/nrd2589
Horakova, O.; Medrikova, D.; Van Schothorst, E.M.; Bunschoten, A.; Flachs, P.; Kus, V.; Kuda, O.; Bardova, K.; Janovska, P.; Hensler, M. Preservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese mice.PLoS One 2012, 7(8),e43764. doi: 10.1371/journal.pone.0043764.
Iskandar, A.; Sriwedari, K.; Wulanda, I.A.; Indra, M.R.; Firani, N.K.; Olivianto, E. The level of chemerin and adipocyte fatty acid binding protein in Toxoplasma gondii seropositive obese individuals. Asian Pacific Journal of Tropical Biomedicine 2017, 7, 107-109. https://doi.org/10.1016/j.apjtb.2016.11.017
Salgado, A.L.F.d.A.; Carvalho, L.d.; Oliveira, A.C.; Santos, V.N.d.; Vieira, J.G.; Parise, E.R. Insulin resistance index (HOMA-IR) in the differentiation of patients with non-alcoholic fatty liver disease and healthy individuals. Arquivos de gastroenterologia 2010, 47, 165-169. doi: 10.1590/s0004-28032010000200009
Kannan, G.; Moldovan, K.; Xiao, J.-C.; Yolken, R.H.; Jones-Brando, L.; Pletnikov, M.V. Toxoplasma gondii strain-dependent effects on mouse behaviour. Folia parasitologica 2010, 57, 151. doi: 10.14411/fp.2010.019
Thjodleifsson, B.; Olafsson, I.; Gislason, D.; Gislason, T.; Jögi, R.; Janson, C. Infections and obesity: A multinational epidemiological study. Scandinavian journal of infectious diseases 2008, 40, 381-386.doi:10.1080/00365540701708293
Weisberg, S.P.; McCann, D.; Desai, M.; Rosenbaum, M.; Leibel, R.L.; Ferrante, A.W. Obesity is associated with macrophage accumulation in adipose tissue. The Journal of clinical investigation 2003, 112, 1796-1808. doi: 10.1172/JCI19246
Arkan, M.C.; Hevener, A.L.; Greten, F.R.; Maeda, S.; Li, Z.-W.; Long, J.M.; Wynshaw-Boris, A.; Poli, G.; Olefsky, J.; Karin, M. IKK-β links inflammation to obesity-induced insulin resistance. Nature medicine 2005, 11, 191-198.doi:10.1038/nm1185
Thomas, D.D.; Corkey, B.E.; Istfan, N.W.; Apovian, C.M. Hyperinsulinemia: an early indicator of metabolic dysfunction. Journal of the Endocrine Society 2019, 3, 1727-1747. doi:10.1210/js.2019-00065
Tahapary, D.L.; Fatya, A.I.; Kurniawan, F.; Marcella, C.; Rinaldi, I.; Tarigan, T.J.; Harbuwono, D.S.; Yunir, E.; Soewondo, P.; Purnamasari, D. Increased intestinal-fatty acid binding protein in obesity-associated type 2 diabetes mellitus. Plos one 2023, 18, e0279915. doi: 10.1371/journal.pone.0279915
Alvite, G.; Esteves, A. Lipid binding proteins from parasitic platyhelminthes. Frontiers in physiology. 2012 ,12;3:363https://doi.org/10.3389/fphys.2012.00363
Pórfido, J. L; Herz, M.; Kiss, F.; Kamenetzky, L.; Brehm, K.; Rosenzvit, M.C.; Córsico, B.; Franchini, G.R. Fatty acid-binding proteins in Echinococcus spp.: the family has grown. Parasitology research. 2020,119:1401-8. https://doi.org/10.1007/s00436-020-06631-5
Lombardo, J.F; Pórfido, J.L; Sisti, M.S.; Giorello, A.N.; Rodríguez, S.; Córsico, B.; Franchini, G.R. Function of lipid binding proteins of parasitic helminths: still a long road. Parasitology Research 2022,12,(4:1117-29. https://doi.org/10.1007/s00436-022-07463-1
Huang, L.; Hu, Y.; Huang, Y.; Fang, H.; Li, R.; Hu, D.; Li, W.; Li, X.; Liang, C.; Yu, X. Gene/protein expression level, immunolocalization and binding characteristics of fatty acid binding protein from Clonorchis sinensis (Cs FABP). Molecular and Cellular Biochemistry 2012, 363:367-76. https://doi.org/10.1007/s11010-011-1189-3
Tang, C.L.; Li, Y.H.; Dai, W.Q.; Zhu, Y.W.; Wu, Z.X.; Li, Y.; Zuo, T. Gene Expression Level, Immunolocalization, and Function of Fatty Acid-Binding Protein from Schistosoma japonicum. The Journal of Parasitology 2021, 107(4), 529-36. https://doi.org/10.1645/19-42.